Blog

Noblie Expands Custom Blades Production and Catalog in U.S. Workshop

Noblie expands its U.S. shop, boosting capacity and models. More custom blades with shorter lead times – folding, EDC, hunting, chef, and collector’s models.

Performance comes first in our shop. This expansion lets us keep core materials on hand, execute designs with less delay, and deliver the custom blades our clients ask for.”

— Aleks Nemtcev

HOUSTON, TX, UNITED STATES, February 3, 2026 /EINPresswire.com/ — Noblie Custom Knives today announced an expansion of its U.S. workshop, increasing capacity for custom blades and adding new models across field, kitchen, and collector categories. The program focuses on faster availability, tighter process control, and a broader catalog while maintaining the company’s emphasis on craft and performance.

The expansion adds workstations for heat treatment, grinding, and finishing, alongside upgraded QC procedures for geometry, hardness, and fit-and-finish. Customers will see shorter lead times on made-to-order builds and more in-stock options in popular formats.

“Performance comes first in our shop,” said Aleks Nemtcev, head maker at Noblie Custom Knives. “This expansion lets us keep core materials on hand, execute designs with less delay, and deliver the custom blades our clients ask for – from daily-carry tools to presentation pieces – without compromising standards.”

What’s new

– Broader catalog: fixed blades – hunting, EDC, Bowie, camping, and chef’s knives, and folding models.

– Materials & methods: top knife steels from stainless and tool (e.g., CPM MagnaCut, RWL34, M398), to Damascus offerings include mosaic variants produced in-house, titanium hardware options, select hardwoods and micarta;

– Finishing & personalization: precision laser engraving or traditional hand engraving available on select builds; custom leather sheaths fitted to each fixed blade.

– Training & documentation: ongoing mentorship of early-career makers and publication of process notes for responsible craft development.

Noblie’s custom work centers on application-driven design: blade geometry and heat treatment are specified first, then aesthetic decisions follow. The company’s ordering process enables customers to select a base platform – folder or fixed – and choose steels, grinds, handle materials, and finishing details appropriate to the intended use.

High-resolution photography, specifications, and current availability are listed online. Domestic and international shipping is offered via express carriers.

About Noblie Custom Knives

Noblie Custom Knives is a U.S. workshop and global retailer specializing in hand-made and machine-assisted knives and custom blades. The company builds and curates pieces in quality steels and rare materials, with long-standing expertise in forging, personalised engraving, and presentation-grade finishing.

Emma J. Hart
Noblie Custom Knives
+1 718-395-3854
email us here

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

February 3, 2026
OSHA Expert Warns Employers Often Overlook Mandatory OSHA 10- and 30-Hour Training Requirements

States and municipalities increasingly require OSHA 10 and 30 training for construction, entertainment, and cannabis work, creating overlooked compliance risks.

Ignoring mandatory OSHA 10- and 30-hour training can block workers from job sites and create serious legal and safety risks for employers.”

— Curtis Chambers, CSP – OSHA Expert

ARLINGTON, TX, UNITED STATES, February 3, 2026 /EINPresswire.com/ — Many employers assume OSHA 10- and 30-hour training is optional, but in numerous states and municipalities, completion of these courses is either legally required or mandated through contract provisions. This misunderstanding exposes employers to compliance violations, project delays, and preventable liability.

While federal OSHA does not mandate OSHA Outreach Training, the agency acknowledges that some states and municipalities require it as a condition of employment. These requirements are established through state statutes, local ordinances, and public contracting rules rather than federal OSHA standards. Employers who rely solely on federal OSHA guidance may overlook enforceable obligations at the state or local level.

Several states currently mandate OSHA 10 and 30-hour training for workers on covered projects. Connecticut, Massachusetts, Missouri, New Hampshire, New York, Rhode Island, West Virginia, and Nevada require OSHA 10 training for employees on specified public works or construction projects. Supervisors are often expected or required to complete OSHA 30 training. Failure to comply can result in workers being denied access to job sites, removal from projects, or penalties against contractors.

Local jurisdictions have also enacted their own training mandates. Miami-Dade County, Florida, requires OSHA 10 training for workers on certain large construction projects. Philadelphia mandates OSHA 10 training for construction and demolition workers and OSHA 30 training for supervisory personnel. New York City enforces OSHA 10 and 30 training as part of its Site Safety Training program, with additional local training hours layered on top of federal outreach courses.

“These requirements are frequently overlooked because employers focus on federal OSHA standards and assume that if OSHA does not mandate the training, it must be optional,” said Curtis Chambers, CSP, a Board Certified Safety Professional and court-recognized expert in OSHA compliance. “In reality, state and local governments have created enforceable training obligations that carry real consequences when ignored.”

Mandatory OSHA outreach training is not limited to traditional construction work. Nevada stands out nationally by extending OSHA 10- and 30-hour training requirements beyond construction. The state requires OSHA outreach training for workers and supervisors in the entertainment industry, including stagehands, rigging crews, lighting, audio, and production personnel. Nevada also mandates OSHA outreach training for employees working in licensed cannabis cultivation and processing facilities, a requirement that many employers entering the industry fail to anticipate.

California is often cited as a state without mandatory OSHA 10 or 30 training requirements, but that perception is incomplete. Under California Assembly Bill 1775, contractors and subcontractors employing workers who set up, tear down, operate, or maintain live events at public entertainment venues owned by the state or any county must ensure those workers complete OSHA outreach training. Non-supervisory workers must complete OSHA 10-hour general industry training, while supervisors and workers with safety responsibilities must complete OSHA 30-hour general industry training before performing covered work.

“California’s live entertainment requirements under A.B. 1775 often surprise employers,” Chambers said. “It is a statutory mandate, not a contractual preference, and it applies specifically to public entertainment venues. Employers who overlook it can find themselves out of compliance before work even begins.”

Even in states without statutory mandates, OSHA 10 and 30 training is frequently required by contract. Owners, developers, general contractors, public agencies, and insurers often specify OSHA outreach training as a prerequisite for site access. These contractual requirements carry the same practical effect as a legal mandate: workers without proof of training may be barred from entering the site.

California remains a prime example of this broader trend. Outside of A.B. 1775 coverage, OSHA outreach training is commonly required through contracts on public works projects, private construction sites, industrial facilities, entertainment productions, and large commercial developments throughout the state. Employers who assume training is unnecessary because it is not universally mandated by statute often discover the requirement only after a contract is awarded or workers are denied access to the job site.

Beyond compliance, OSHA outreach training provides employers with a standardized baseline of safety awareness. While OSHA 10 and 30 training does not replace job-specific instruction required by OSHA standards, it helps workers recognize common hazards, understand employer and employee responsibilities, and identify when additional controls or training are necessary.

While employers can hire an OSHA-authorized trainer to conduct a class at their site, many employers operating across multiple jurisdictions now use online OSHA 10 and 30 training courses to address both mandatory requirements and contractual obligations. Online training allows workers to complete required coursework before reporting to a job site, reducing administrative burdens and minimizing delays caused by last-minute compliance issues.

As states and municipalities continue to adopt their own safety and training requirements, employers are encouraged to review applicable laws, ordinances, and contract documents carefully rather than relying solely on federal OSHA standards. Understanding state and local OSHA training requirements, as well as common contractual expectations, is essential for avoiding compliance gaps and maintaining uninterrupted operations.

About Curtis Chambers, CSP

Curtis Chambers, CSP, is a Board Certified Safety Professional and court-recognized OSHA compliance expert. He provides on-site and online OSHA training, including 10- and 30-hour courses, for construction and general industry operations. Learn more and access his training resources at https://oshatraining.com

.

Curtis Chambers, CSP
oshatraining.com
curtis.chambers@oshatraining.com
Visit us on social media:
Facebook
YouTube

Differences Between OSHA 10 training and OSHA 30 training

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

February 3, 2026
The Houstonian Hotel, Club & Spa Introduces the Trellis Getaway: A Rendezvous Rooted in Luxury and Wellness

This escape features Trellis Spa indulgence, early arrival, welcome cocktails, and a nightly $200 spa credit.

HOUSTON, TX, UNITED STATES, January 26, 2026 /EINPresswire.com/ — The Houstonian Hotel, Club & Spa invites couples to escape into refined relaxation with the new Trellis Getaway, a thoughtfully curated hotel package designed for romance, renewal, and indulgence.

Recently named Travel + Leisure’s #1 Resort in Texas, The Houstonian pairs its legendary hospitality with its award-winning Trellis Spa to create an effortless romantic retreat. Guests enjoy specially priced accommodations, early noon check-in, two handcrafted welcome cocktails, and a $200 nightly spa credit to luxuriate at Trellis Spa.

At Trellis, couples may choose from a full menu of restorative experiences, including signature massages, customized facials, revitalizing body treatments, and indulgent spa rituals ideal for two. The credit may also be applied toward spa dining, gratuities, or Trellis Spa boutique purchases, allowing guests to tailor their stay to their personal wellness preferences.

Beyond the spa, the Trellis Getaway hotel package includes access to the exclusive Houstonian Club, three temperature-controlled pools, a curated calendar of events, complimentary self-parking, no resort fees, and a flexible 48-hour cancellation policy.

Blending romance with elevated wellness, the Trellis Getaway is an ideal weekend rendezvous, where time slows, senses awaken, and connection takes center stage.

Package details:
The Trellis Getaway must be booked at least seven days in advance and is based on availability. Not available for groups. The $200 spa credit is per room, per night, applied at checkout to Trellis Spa services and holds no cash value.

For reservations or more information, visit www.Houstonian.com.

—
About The Houstonian Hotel, Club & Spa
Set on 27 secluded acres in the heart of Houston, The Houstonian is an iconic independent luxury destination known for its world-class wellness offerings, exceptional service, and timeless elegance.

Seliece Womble
The Houstonian Hotel, Club & Spa
+1 713-680-2626
email us here
Visit us on social media:
Instagram
Facebook

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

February 3, 2026
Naturopathie Animale : Guide Gratuit Pour le Bien-Être de Votre Chien

L’École de Naturopathie et Sophrologie publie un guide sur la naturopathie animale destiné aux passionnés souhaitant améliorer le bien-être de leur chien.

Ce guide gratuit permet aux passionnés de découvrir comment la naturopathie peut améliorer naturellement la santé et le bien-être de leur chien en complément du suivi vétérinaire.”

— Eva Mischler, Formatrice École-Naturo.fr

PARIS, FRANCE, January 26, 2026 /EINPresswire.com/ — L’École de Naturopathie et Sophrologie annonce la publication d’un guide gratuit consacré à la naturopathie animale, une approche naturelle et holistique pour améliorer le bien-être des chiens. Ce document s’adresse aux propriétaires d’animaux et aux passionnés de naturopathie désireux d’adopter des méthodes naturelles pour accompagner la santé de leur compagnon.

Une approche holistique pour la santé animale

La naturopathie animale constitue une discipline complémentaire qui vise à renforcer la vitalité et le bien-être des animaux domestiques par des solutions naturelles. Cette approche globale prend en compte la dimension physique, émotionnelle et environnementale de l’animal pour proposer des accompagnements personnalisés.

Contrairement aux interventions symptomatiques, la naturopathie animale cherche à identifier et traiter les causes profondes des troubles observés : stress chronique, déséquilibres digestifs, allergies cutanées, fatigue ou troubles comportementaux. L’objectif est de soutenir l’homéostasie, c’est-à-dire la capacité naturelle de l’organisme à maintenir son équilibre interne malgré les variations environnementales.

“La naturopathie animale permet d’accompagner les chiens et les chats en respectant leur rythme naturel et leur intégrité physique, tout en restant en synergie avec le suivi vétérinaire traditionnel”, explique Claire Moreau, naturopathe animalière certifiée depuis 2019.

Cette approche complémentaire ne remplace jamais les soins vétérinaires indispensables, mais offre des solutions additionnelles pour optimiser la qualité de vie de l’animal et prévenir l’apparition de troubles chroniques.

Les principaux piliers de la naturopathie animale

Le guide publié par l’École de Naturopathie et Sophrologie détaille les cinq piliers fondamentaux de cette discipline appliquée aux animaux domestiques.

Le premier pilier concerne la nutrition personnalisée. L’alimentation représente un facteur déterminant de la santé animale. Les recommandations nutritionnelles sont adaptées à l’âge, la race, le niveau d’activité physique et les besoins spécifiques de chaque animal. L’approche privilégie des aliments naturels, peu transformés et équilibrés pour prévenir les carences et les surcharges métaboliques.

Le deuxième pilier porte sur la phytothérapie, c’est-à-dire l’utilisation de plantes médicinales pour soutenir les fonctions physiologiques. Les protocoles phytothérapiques sont établis selon les besoins identifiés lors du bilan de vitalité et respectent les contre-indications spécifiques aux animaux.

Le troisième pilier concerne la gestion émotionnelle. Les animaux domestiques sont sensibles au stress environnemental, aux changements de routine et aux émotions de leur entourage. Des techniques douces comme les fleurs de Bach, la relaxation ou les soins énergétiques permettent d’apaiser les tensions émotionnelles et de restaurer l’équilibre comportemental.

Le quatrième pilier repose sur les techniques manuelles douces : massages canins, réflexologie, techniques énergétiques. Ces pratiques favorisent la détente musculaire, stimulent la circulation et renforcent le lien entre l’animal et son propriétaire.

Le cinquième pilier intègre l’analyse de l’environnement de vie de l’animal. La géobiologie du lieu de vie, les sources de stress potentielles, l’agencement des espaces et les interactions sociales sont évalués pour optimiser le cadre de vie et prévenir les déséquilibres.

Quand consulter un naturopathe animalier : les signaux d’alerte

Le guide identifie plusieurs situations dans lesquelles un accompagnement naturopathique peut être bénéfique pour l’animal. Les troubles cutanés représentent un motif fréquent de consultation : démangeaisons chroniques, pelage terne, perte de poils excessive ou irritations cutanées.

Les déséquilibres digestifs constituent également un signal d’alerte : appétit irrégulier, troubles du transit, vomissements récurrents ou sensibilités alimentaires. Ces manifestations peuvent indiquer des intolérances, des déséquilibres de la flore intestinale ou des facteurs émotionnels sous-jacents.

Les troubles comportementaux et émotionnels justifient aussi un accompagnement : anxiété de séparation, agressivité inhabituelle, hyperactivité, troubles du sommeil ou réactions excessives aux stimuli environnementaux. La naturopathie animale propose des outils naturels pour apaiser ces manifestations sans recourir systématiquement à des traitements médicamenteux.

La baisse de vitalité, notamment chez les animaux âgés ou convalescents, bénéficie également d’un soutien naturopathique pour stimuler l’énergie vitale, faciliter la récupération et accompagner le vieillissement dans les meilleures conditions.

Le déroulement d’une consultation en naturopathie animale

Le guide décrit le processus de consultation qui débute par un bilan de vitalité complet, généralement d’une durée d’une heure, réalisable en présentiel ou à distance. Un questionnaire préparatoire permet d’analyser plusieurs dimensions : l’environnement de vie, les habitudes alimentaires, le niveau d’activité physique, l’historique médical et les particularités comportementales.

Ce bilan approfondi permet d’établir un programme personnalisé intégrant des conseils nutritionnels, des recommandations phytothérapiques, des fleurs de Bach adaptées, des techniques de relaxation et des ajustements environnementaux. Un espace numérique sécurisé facilite l’échange de documents et le suivi régulier de l’évolution de l’animal.

L’accompagnement naturopathique s’ajuste progressivement selon les progrès observés, permettant une amélioration durable de la qualité de vie de l’animal et un renforcement du lien avec son propriétaire.

Un marché en croissance soutenue

Le secteur des médecines alternatives pour animaux connaît une croissance significative en France. Selon les données sectorielles, 71 % des Français ont consulté au moins une fois une médecine douce depuis 2019, et cette tendance s’étend progressivement au domaine vétérinaire.

Le marché français du bien-être et de la santé naturelle représente 37,5 milliards d’euros de chiffre d’affaires avec une croissance annuelle de 7 %. Cette dynamique reflète une demande croissante pour des approches respectueuses de la physiologie animale et moins invasives.

Les propriétaires d’animaux recherchent de plus en plus des solutions naturelles pour accompagner leurs compagnons, en complément du suivi vétérinaire classique. Cette évolution des attentes génère de nouvelles opportunités professionnelles pour les praticiens formés en naturopathie animale.

RAYES ANTOINE
ECOLE DE NATUROPATHIE & SOPHROLOGIE
+33 756813444
email us here
Visit us on social media:
LinkedIn
YouTube

Transformez votre passion en carrière avec la naturopathie !

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

February 3, 2026
Parson James Releases New Single “Water Me”
A Bold Return Thirsting For Light, Growth & Hope

Listen Here

LONDON, UK / MusicWire / Jan. 23, 2026 — Singer-songwriter Parson James, the genre-blending artist behind the multi-platinum global smash “Stole The Show,” returns with “Water Me”, a deeply personal soft-release single crafted for the fans who’ve supported him since day one and setting the stage for the bold comeback anthems arriving next.

Born in South Carolina and now based between Nashville and London, Parson’s work has always lived in contrast of struggle and resilience, gospel and EDM, soul and euphoria/ Water Me marks a moment where his internal landscapes finally catch up with his fullest creative intention.

Parson has spent nearly a decade honing not just his sound but his story. From releasing his debut EP and single almost 10 years ago, he admits he’s rewritten versions of his album many times over, always chasing a moment when his life-experiences, vulnerability and songcraft align. Only within the past few years has he felt that his growth, self-awareness and honesty would finally allow that alignment. With “Water Me”, Parson doesn’t just share a song, he shares an inner turning point.

In “Water Me”, Parson confronts a familiar but often avoided truth: that even the strongest among us can run utterly dry. A “withering flower in need of a little love”, he confesses he’s never been one to ask, always pushing forward regardless of his capacity. But after a tough patch in 2021, mistakes made, lessons learned, he realizes he can’t do it all alone. He’s tired. He’s depleted. Yet, he’s poised to grow if someone just offers light, water, safety, love.‍

That water becomes metaphor, plea and promise all in one. The track is as much an emotional reclamation as it is an invitation for anyone listening to feel seen: that asking isn’t weakness, that growth can come even at your lowest.

Musically, “Water Me” draws from Parson’s lifelong fascination with gospel’s heartfelt roots, the organic simplicity of soulful balladry and the emotional directness of country-twang. During its creation, Chris Stapleton and gospel music rotated heavily in Parson’s world, shaping a sonic atmosphere that is intimate, raw, yet expansive.

His writing process here, as always, feels like an internal conversation laid bare: therapy set to melody, harmonies rising out of honesty. Choir-like vocals whisper and soar. Vocal grit and quiet space intertwine. The production leans toward organic textures, letting the emotional core live uncluttered.

“Pour yourself a whiskey (or a non-alcoholic hot cider if that’s your preference), wrap up in your favorite blanket. If you can, find a fire (literal or figurative), sway with someone who holds you. By the bridge, you should be standing, belting, maybe crying, utterly lost in the comfort of the moment.”

Above all, hope. Parson wants listeners to recognize their own worth: that the parts of you that feel frayed, unappreciated, misunderstood. Those are not liabilities, they’re markers of what makes you uniquely you. He wants people to love themselves, celebrate their quirks and embrace honesty. Because, in his vision, those become foundations of strength.

This song itself emerges from collaboration with Parson’s trusted circle, friends and artists who bring voice, craft and co-vision. Longtime friend and Grammy-nominated artist Joanna “JoJo” Levesque lends background vocals, adding warmth and familiarity that reflect their real-life bond and shared musical history. Her presence in the studio brought an ease and emotional resonance that carries through the record.

Additional keys were played by Phil Lewis, who has since gone on to work extensively with Doja Cat, bringing a subtle modern touch to the song’s otherwise organic palette. His contributions help bridge the track’s soulful roots with a contemporary edge, underscoring Parson’s genre-blending instincts.

The visual world around “Water Me” will honor that same honesty: minimal, emotive, rooted in light and shadow, growth and fragility. Just like the song, it’ll invite you in rather than push you back.

Beyond music, Parson continues to stand for causes that deeply matter: queer youth, mental health, HIV/AIDS awareness. He works closely with organizations such as The Trevor Project, GLAAD, LoveLoud, and amfAR. His identity as queer biracial artist from the conservative South is not just an origin story, it’s a lens through which he lives, creates, and advocates.

Parson James

Market Drivers/Career Highlights
- Over 1.2 billion streams globally
- Stole The Show has gone multi-platinum, with awards and milestones in the USA, UK, France, and beyond
- 30× Platinum across the world; Diamond certified in France
- More than 15 million Shazams
- Honored as New Zealand’s honorary ambassador, key to the city of Opotiki
- High-profile syncs including Grey’s Anatomy, Love Island, The Voice, Real Housewives, The Originals, American Idol (winning song)
- Extensive live credentials: Coachella (three times), AMFAR Galas with Diana Ross and Christina Aguilera, appearances on Ellen, Fallon, Seth Meyers, plus iconic venues like MSG, Hollywood Bowl, Greek Theater, etc.
Connect with Parson James:

Instagram | TikTok
Press Shot

About

About Parson James:

Parson James is a singer, songwriter and performer whose genre-blending sound and deeply emotional storytelling have positioned him as one of the most distinctive voices in modern pop and dance music. Best known for co-writing and performing on Kygo’s multi-platinum hit “Stole The Show,” which has surpassed 1 billion streams globally, Parson has spent the last decade captivating audiences across streaming platforms, global charts and stadium stages.

Born in South Carolina and now based between Nashville and London, Parson’s music is rooted in contrast, soul and euphoria, gospel and EDM, struggle and resilience. His perspective as a queer, biracial artist raised in the conservative South has shaped a narrative that is as emotionally powerful as it is culturally important.

Following his breakout with “Stole The Show,” Parson has toured the world alongside Kygo and collaborated with a range of top-tier artists including Sam Feldt, The Knocks, Vandelux, Said the Sky, Audien, CAZZETTE, Hook N Sling, Big Gigantic and others. His solo releases, including the Temple EP (RCA), “Only You,” “Little Fires,” and “Right Now,” reflect an evolving voice that pairs cinematic vocals with bold, genre-spanning production.

Media Contact

Tenace Records

View source version on MusicWire: press release

SOURCE: MusicWire
February 3, 2026
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, CEO Dr Raza Bokhari joined Steve Darling from Proactive https://youtu.be/8EErx6aQEXs to announce that the company was honored with the opportunity to ring the Nasdaq Opening Bell at the Nasdaq MarketSite in New York’s Times Square, marking the one-year anniversary of Medicus’ listing on the Nasdaq exchange.

Dr. Bokhari said the milestone reflects the company’s progress since going public and highlights its continued focus on disciplined execution across a streamlined and strategically selected clinical portfolio. Since its Nasdaq debut, Medicus has concentrated on advancing key therapeutic assets through Phase 2 proof-of-concept studies while actively pursuing licensing opportunities and strategic partnerships with established pharmaceutical companies that are well positioned to manage late-stage development and global commercialization.

Medicus’ current development pipeline is anchored by two lead programs. SkinJect is a localized, immunogenic precision therapy being developed for the treatment of basal cell carcinoma, the most common form of skin cancer. The company estimates SkinJect addresses a market opportunity of approximately $2 billion.

The pipeline also includes Teverelix, a next-generation gonadotropin-releasing hormone (GnRH) antagonist designed for patients with advanced prostate cancer who are at high cardiovascular risk and susceptible to acute urinary retention relapse. Medicus estimates the combined market opportunity for its pipeline assets at approximately $6 billion. The company announced today that the royalty rate payable on worldwide net sales of Teverelix has been reduced from ~4% to 2%, with the royalty term clarified on a country-by-country basis in line with standard industry practice. The company says this makes Teverelix more attractiveness for future partnering.

The video of the proactive interview is available by clicking on this link https://youtu.be/8EErx6aQEXs

For further information contact:

Carolyn Bonner, President and Chief Financial Officer
(610) 636-0184
cbonner@medicuspharma.com

Anna Baran-Djokovic, SVP Investor Relations
(305) 615-9162
adjokovic@medicuspharma.com

About Medicus Pharma Ltd.
Medicus Pharma Ltd. (Nasdaq:MDCX) is a precision-guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets. The Company is actively engaged in multiple countries across three continents.

SkinJect Inc., a wholly owned subsidiary of Medicus Pharma Ltd., is a development-stage life sciences company focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumor cells. The Company completed a Phase 1 study (SKNJCT-001) in March of 2021, which met its primary objective of demonstrating safety and tolerability; the study also describes the efficacy of the investigational product doxorubicin-containing microneedle arrays (D-MNA), with six participants experiencing complete response on histological examination of the resected lesion. The Company is currently conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. The Company has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the United Arab Emirates.

In August 2025, the Company announced its entry into a non-binding memorandum of understanding (MoU) with Helix Nanotechnologies, Inc. (HelixNano), a Boston-based biotech company focused on developing a proprietary advanced mRNA platform, in respect of their shared mutual interest in the development or commercial arrangement contemplated by the MoU. The MoU is non-binding and shall not be construed to obligate either party to proceed with a joint venture or any further development or commercial arrangement, unless and until definitive agreements are executed.

In August 2025, the Company completed the acquisition of Antev, a UK-based late clinical stage biotech company, developing Teverelix, a next-generation gonadotrophin-releasing hormone (GnRH) antagonist, as a first-in-market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse (AURr) episodes due to enlarged prostate.

Unlike GnRH agonists, which can cause an initial surge in testosterone levels, Teverelix directly suppresses sex hormone production without this surge, potentially reducing cardiovascular risks. This mechanism is particularly beneficial for patients with existing cardiovascular conditions. Teverelix is formulated as a microcrystalline suspension, allowing for sustained release and a six-week dosing interval, which may improve patient compliance and outcomes .

In September 2020, Antev completed a Phase 1 clinical trial in which Teverelix was shown to be well tolerated with no dose-limiting toxicities and demonstrated rapid testosterone suppression. The study included 48 healthy male volunteers. In February 2023, Antev also completed a Phase 2a study in 50 patients with advanced prostate cancer (APC), where Teverelix achieved the primary endpoint of greater than 90% probability of castration levels of testosterone suppression (97.5%) but the secondary endpoint of maintaining this rate above 90% was not met, with the probability dropping to 82.5% by Day 42.

In January 2023, the U.S. Food and Drug Administration (FDA) reviewed the Phase 1 and Phase 2a data and provided written guidance on Antev’s proposed Phase 3 trial design for Teverelix. This milestone supports the Company’s clinical plans to develop Teverelix as a treatment for advanced prostate cancer patients with increased cardiovascular risk.

In December 2023, the FDA approved the Phase 2b study design in advanced prostate cancer covering 40 patients.

In November 2024, the FDA approved the Phase 2b study design in AURr covering 390 patients.

In October 2025, the Company announced a strategic collaboration with the Gorlin Syndrome Alliance (GSA) to advance compassionate access to SkinJect for patients suffering from Gorlin Syndrome, also known as nevoid basal cell carcinoma syndrome.

Under the collaboration, Medicus and the GSA will jointly pursue the Expanded Access IND Program with the FDA to allow patients with multiple, recurrent, or inoperable basal cell carcinomas (BCCs) to access SkinJect under physician-supervised treatment protocols. The initiative aims to establish a framework for expanded access while collecting valuable real-world safety and tolerability data to inform future regulatory filings. It will also more tightly integrate patient community-led insights and data into the design, monitoring, and long-term development of SkinJect in this rare disease population.

In November 2025, the Company received full regulatory and ethical approvals in the United Kingdom to expand its ongoing Phase 2 clinical study (SKNJCT-003) evaluating D-MNA to non-invasively treat BCC of the skin. The approvals were issued by the Medicines and Healthcare products Regulatory Agency (MHRA), the Health Research Authority (HRA) and the Wales Research Ethics Committee (WREC). The MHRA approval followed a comprehensive scientific review of the Investigational Medicinal Product Dossier (IMPD) and protocol. The WREC issued a favorable ethical opinion, and the HRA granted study-wide governance approval, confirming compliance with UK Good Clinical Practice and National Health Service capacity and capability standards.

In December 2025, the Company announced that it has successfully completed enrolment of 90 patients in the United States for Phase 2 clinical study (SKNJCT-003) evaluating D-MNA to non-invasively treat BCC of the skin. The Company expects to release topline results for SKNJCT-003 in the first quarter of 2026 and secure an end-of-Phase 2 meeting with the FDA in the first half of 2026.

In December 2025, Medicus announced a non-binding letter of intent with Reliant AI Inc., a decision-intelligence company specializing in generative AI for the life sciences industry, to collaborate on the development of an AI-driven clinical data analytics platform. Subject to execution of definitive agreements, the platform is expected to support capital-efficient clinical development through data-driven dynamic clinical-site selection, patient stratification and enrollment forecasting. The initial phase of the collaboration is expected to support an upcoming Teverelix clinical study planned for 2026, with potential expansion into later-stage development programs in collaboration with a strategic partner.

Cautionary Notice on Forward-Looking Statements
Certain information in this news release constitutes “forward-looking information” under applicable securities laws. “Forward-looking information” is defined as disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action and includes, without limitation, statements regarding the Company’s leadership and prospects, the collaboration with GSA including the potential benefits thereof for GSA, those suffering with Gorlin Syndrome and Medicus (including as it relates to the development of SkinJect™), ability to be approved for the Expanded Access IND Program to enable those suffering with Gorlin Syndrome to access SkinJect™ under physician-supervised treatment protocols, the development of Teverelix and expectations concerning, and future outcomes relating to, the development, advancement and commercialization of Teverelix for AURr, high CV risk prostate cancer, women’s health indications like endometriosis, and the potential market opportunities related thereto, the MOU, including the potential signing of definitive agreements between Medicus and HelixNano and the development of thermostable infectious diseases vaccines by combining HelixNano’s proprietary mRNA vaccine platform with Medicus’s proprietary microneedle array (MNA) delivery platform, the Company’s aim to fast-track the clinical development program and convert the SKNJCT-003 exploratory clinical trial into a pivotal clinical trial, and approval from the FDA and the timing thereof, including with respect to the Company’s submission for approval in the FDA Commissioner’s National Priority Voucher program, plans and expectations concerning, and future outcomes relating to, the development, advancement and commercialization of SkinJect through SKNJCT-003 and SKNJCT-004, and the potential market opportunities related thereto, the Company’s expectation to release topline results for SKNJCT-003 in the first quarter of 2026 and to secure an EOP2 meeting with the FDA in the first half of 2026, entry into definitive documents with Reliant and the expected terms thereof, engaging in proposed Medicus-sponsored studies currently contemplated in the Reliant non-binding letter of intent and the expected benefits thereof, the expansion of SKNJCT-003 into the United Kingdom and the potential benefits therefrom, the advancement of the SKNJCT-004 study and the potential results of and benefits of such study. Forward-looking statements are often but not always, identified by the use of such terms as “may”, “on track”, “aim”, “might”, “will”, “will likely result”, “could,” “designed,” “would”, “should”, “estimate”, “plan”, “project”, “forecast”, “intend”, “expect”, “anticipate”, “believe”, “seek”, “continue”, “target”, “potential” or the negative and/or inverse of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including those risk factors described in the Company’s annual report on form 10-K for the year ended December 31, 2024 (the “Annual Report”), and in the Company’s other public filings on EDGAR and SEDAR+, which may impact, among other things, the trading price and liquidity of the Company’s common shares. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof and thus are subject to change thereafter. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

SOURCE: Medicus Pharma Ltd

View the original press release on ACCESS Newswire

February 3, 2026
ARS is Voted One of the ‘Best Places to Work’ in the North Bay

ARS Roofing & Gutters earns 2025 Best Places to Work, celebrating an inclusive culture, strong teamwork, and community impact across the North Bay.

…for them to vote after working here for 20 years and still be able to say ‘this is the best place to work,’ I feel that tells our clients who we are are a company.”

— Letitia Hanke

SANTA ROSA, CA, UNITED STATES, January 23, 2026 /EINPresswire.com/ — ARS Roofing & Gutters, a leading roofing and gutter contractor in Sonoma County, has been honored as one of the Best Places to Work by The Press Democrat’s North Bay Business Journal in its 20th anniversary edition. This prestigious recognition celebrates ARS’s unique workplace culture, deep commitment to employee wellbeing, and ongoing leadership in diversity within the construction industry.

“We treat each other like family,” says Letitia Hanke, founder and CEO of ARS Roofing. “And support one another both professionally and personally. Integrity, excellence and community service are at the core of what we do.”

When Reliability is Everything, Culture is the Advantage

The award was determined through employee-submitted surveys that scored businesses on collaboration, community support, and company culture. With 80% of ARS’s upper management identifying as women or minorities—a rarity in the roofing sector—ARS stands as a beacon of inclusion in an industry where just 2% of roofers are women and 8% are Black.

Through regular employee appreciation events, community service days, and transparent promotion-from-within policies, ARS fosters a sense of unity that goes far beyond the job site.

In a standout moment shared by Hanke, the team was asked to vote for Employee of the Year based on reliability, trustworthiness, and teamwork. The winner was selected by over half the company—proof that ARS’s values are more than words, they’re woven into daily operations.

Why It Matters to the Community

For customers, this recognition translates to a better experience.

Happy employees lead to happy homes.

“Many of my employees have been with me for 15, 20 years,” Hanke explains. “And for them to vote after working here for 20 years and still be able to say, this is the best place to work, I feel that tells our client who we are as a company.”

Customers can count on long-term stability and trusted expertise. This kind of retention in the trades is rare, and it shows in the quality of work and service ARS delivers.

Beyond Roofing: A Vision for Change

Under Hanke’s leadership, ARS Roofing is building more than roofs; they’re helping build futures. Through its nonprofit, The LIME Foundation, ARS helps train underserved youth for careers in the trades via the Nextgen Trades Academy. The company also donates up to 5% of net profits from each job to support this mission.

As ARS looks ahead to expanding its team and deepening community impact, this award affirms its role not just as a contractor, but as a community cornerstone.

Devin Halliday
on behalf of ARS Roofing
+1 707-843-3714
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
Other

ARS Voted Best Place to Work 2025

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

February 3, 2026
6th Annual Online Homebuyer Mystery Shop Report Released

Online Sales Counselors continue to perform as adoption declines

Speed matters, but structure matters more. OSCs bridge the gap between marketing and onsite sales by responding quickly while building a real human connection that automation alone can’t replace.”

— Leah Fellows, President of Blue Gypsy, Inc.

ATLANTA, GA, UNITED STATES, January 23, 2026 /EINPresswire.com/ — The 6th Annual Online Homebuyer Mystery Shop Report has been released, offering an in-depth look at how today’s home builders respond to online buyer inquiries and where performance gaps persist. Conducted for the sixth consecutive year by Melinda Brody & Company in partnership with Blue Gypsy Inc. and Denim Marketing, the study benchmarks lead response speed, follow-up quality, communication channels and the impact of Online Sales Counselors (OSCs) across the industry.

The 2025 report analyzed 50 builders across five segments, ranging from national production builders to small local builders. Mystery shoppers submitted online inquiries during normal business hours. Builder responses were tracked over 30 days, evaluating email, phone, text and video follow-up, as well as overall persistence and personalization.

One of the most notable findings this year is the continued decline in OSC adoption, despite improving OSC performance. In 2025, 70 percent of builders surveyed employed OSCs, down from 78 percent in 2024. Despite the drop, builders with OSCs consistently outperformed those without across nearly every metric measured, reinforcing the value of a structured online sales program.

“Speed matters, but structure matters more. OSCs bridge the gap between marketing and onsite sales by responding quickly while building a real human connection that automation alone can’t replace,” comments Leah Fellows, President, Blue Gypsy.

Speed to lead remains a critical challenge. No builders responded to an online inquiry with a personalized email within five minutes; 20 percent replied within 30 minutes, and 24 percent within four hours. More concerning, 22 percent of builders never sent a personalized email at all! The gap between OSC and non-OSC builders remains stark: 73 percent of builders without OSCs failed to send a single personalized email, compared to just 3 percent of OSCs in 2025, a significant improvement from 13 percent the prior year.

“Marketing doesn’t stop when the lead comes in. This report reinforces that great marketing must be supported by strong follow-up, or even the best campaigns lose momentum,” adds Carol Morgan, President, Denim Marketing.

Phone follow-up declined overall, with only 58 percent of builders making a phone call, down eight points from 2024. However, every call made within five minutes came from an OSC, and approximately 90 percent of builders with OSCs made at least one phone call, compared to just 10 percent of builders without OSCs.

The report also highlights increased use of newer communication channels. Text messaging was used by 62 percent of builders, up 12 points year over year, while video emails rose to 34 percent, also a 12-point increase. Notably, 100 percent of video emails were sent by OSCs, underscoring their role in driving more personalized, human engagement.

Overall, 66 percent of builders achieved five or more personalized touchpoints across at least two communication channels, showing continued progress toward more consistent follow-up. Still, the data reveals wide variability in execution, with some builders responding within minutes and others waiting weeks to make initial contact.

“The biggest takeaway from this year’s mystery shop is the importance of process. Builders that commit to structured follow-up outperform those relying on sporadic outreach or heavy automation,” states Ben Marks, President, Melinda Brody & Company.

Now in its sixth year, the Online Homebuyer Mystery Shop has become a trusted benchmarking tool for home builders, sales leaders and marketing teams. The findings reinforce a clear takeaway: technology alone is not enough. Builders that combine structure, accountability and personalized follow-up consistently deliver a stronger buyer experience and better lead conversion.

The full 6th Annual Online Homebuyer Mystery Shop Report is now available for download at DenimMarketing.com/onlinemysteryshop.

Visit DenimMarketing.com to sign up for the Denim newsletter, view the full portfolio and more. Call 770-383-3360 for information on packages and finding the perfect fit with Denim Marketing. Morgan encourages you to “Try us on for size; you will find Denim to be comfortable, reliable and personal. Our agency isn’t one size fits all – neither are jeans!”

About Denim Marketing:
Whether stonewashed, faded or indigo blue, Denim Marketing’s marketing strategies are tailored to each client’s needs and niche. Established in 1999 as Flammer Relations, Denim Marketing began with a focus on public relations services for clients. The company has expanded its services over the years to become a full-service strategic marketing agency specializing in strategic marketing, media relations, blogging, social media, promotions, advertising and much more. Denim Marketing aims to be a go-to source for companies seeking a comfortable fit, strong relationships and results. Stay in touch with Denim Marketing by signing up for the newsletter at www.DenimMarketing.com and following @DenimMarketing on social media. For more information, call 770-383-3360 or email Carol@DenimMarketing.com.

Carol L Morgan
Denim Marketing
+1 770-383-3360
email us here

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

February 3, 2026
FormClue.io Debuts Lead Certification Platform to Help Businesses Reduce Compliance Risk

New solution focuses on documentation, verification, and defensibility of consumer leads

PHOENIX, AZ, UNITED STATES, January 23, 2026 /EINPresswire.com/ — FormClue.io announced the launch of its lead compliance platform designed to help businesses reduce operational and legal risk associated with consumer lead acquisition and outreach.

As enforcement and litigation tied to consumer communications continue to rise, businesses involved in lead generation and remarketing are increasingly expected to demonstrate how leads were sourced, when consent was captured, and how data moved through their systems. FormClue addresses this need by creating a verifiable certification record the moment a lead is generated.

The announcement comes at a time when the lead compliance sector has historically been served by a limited number of established providers, including TrustedForm and Jornaya, making new market entrants uncommon. Industry observers note that additional platforms may provide businesses with greater flexibility as compliance requirements continue to evolve.

The platform is intended to support advertisers, publishers, lead buyers, and call centers by providing recorded signup activity that can be viewed and referenced internally or shared with partners. By standardizing how lead activity is recorded, FormClue helps organizations identify gaps, improve accountability, and strengthen compliance workflows.

In addition to its compliance functionality, FormClue offers a pricing structure designed to lower adoption risk. Businesses can create free accounts, avoid long-term contracts, and use credits only as needed. This approach allows teams to implement compliance measures incrementally rather than committing to fixed costs.

FormClue also maintains a strict data-use policy, stating that it does not sell or commercially exploit customer data processed through the platform.

The company’s release comes amid growing industry focus on proactive compliance strategies and defensible data practices.

About FormClue
FormClue.io is a lead-certification and compliance platform built to help businesses document and verify consumer lead activity. The company serves organizations across lead generation, performance marketing, and customer acquisition.

Scott Heistand
FormClue.io
+1 717-620-9609
scott.h@formclue.io

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

February 3, 2026
SK Labs Earns NSF/ANSI 455-2 GMP Certification with ‘A’ Rating

ANAHEIM, CA, UNITED STATES, January 23, 2026 /EINPresswire.com/ — SK Labs, a contract manufacturer specializing in dietary supplement capsules, tablets, and powders, has earned NSF/ANSI 455-2 Good Manufacturing Practices (GMP) certification with an “A” rating from NSF, an independent public health and safety organization.

The NSF/ANSI 455-2 certification verifies that SK Labs meets rigorous GMP requirements for dietary supplements, including quality management systems, personnel training, sanitation, equipment, and ingredient traceability. Certification also requires documented corrective actions, validated processes, and detailed recordkeeping.

In addition to NSF GMP certification, SK Labs is also NSF Certified for Sport^® and holds UL GMP Certification, resulting in a dual GMP-certified operation. These credentials reflect SK Labs’ commitment to maintaining a tightly controlled, quality-driven manufacturing environment for clients in both general wellness and sports nutrition markets.

“The NSF audit process is one of the most comprehensive in the industry,” said a spokesperson for SK Labs. “Achieving an ‘A’ rating demonstrates our team’s discipline, accountability, and proactive commitment to quality at every step of the production process.”

The Anaheim-based facility produces capsules, tablets, stick packs, and powders, offering both bulk and finished goods. Certification supports brand partners with streamlined onboarding, enhanced retail credibility, and reduced regulatory risk.

To learn more about SK Labs and its certified manufacturing capabilities, visit www.sklabs.com

About NSF
NSF is an independent, global services organization dedicated to improving human and planet health for more than 80 years by developing public health standard and providing world-class testing, inspection, certification, advisory services and digital solutions to the food, nutrition, water, life sciences and consumer goods industries. NSF has 40,000 clients in 110 countries and is a World Health Organization (WHO) Collaborating Center on Food, Safety, Water Quality and Medical Device Safety.

Kurtis Patel
SK Labs
+1 714-695-9800
email us here
Visit us on social media:
LinkedIn
YouTube
Other

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

February 3, 2026